skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Detection and prevention of mycoplasma hominis infection

Abstract

The present invention is directed to a rapid and sensitive method for detecting Mycoplasma hominis using M. hominis-specific probes, oligonucleotides or antibodies. In particular a target sequence can be amplified by in vitro nucleic acid amplification techniques, detected by nucleic acid hybridization using the subject probes and oligonucleotides or detected by immunoassay using M. hominis-specific antibodies. M. hominis-specific nucleic acids which do not recognize or hybridize to genomic nucleic acid of other Mycoplasma species are also provided.

Inventors:
 [1];  [2];  [3]
  1. (Scranton, PA)
  2. (Philadelphia, PA)
  3. (San Antonio, TX)
Publication Date:
Research Org.:
United States Air Force
OSTI Identifier:
870792
Patent Number(s):
US 5595871
Application Number:
08/112,816
Assignee:
University of Scranton (Scranton, PA); Research Corporation Technologies, Inc. (Tucson, AZ) OSTI
DOE Contract Number:
F49620-85-C001; F49620-88-C0053
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
detection; prevention; mycoplasma; hominis; infection; directed; rapid; sensitive; method; detecting; hominis-specific; probes; oligonucleotides; antibodies; particular; target; sequence; amplified; vitro; nucleic; acid; amplification; techniques; detected; hybridization; subject; immunoassay; acids; recognize; hybridize; genomic; species; provided; acid hybridization; nucleic acid; nucleic acids; target sequence; specific nucleic; specific probe; acid amplification; sensitive method; mycoplasma hominis; /435/999/

Citation Formats

DelVecchio, Vito G., Gallia, Gary L., and McCleskey, Ferne K.. Detection and prevention of mycoplasma hominis infection. United States: N. p., 1997. Web.
DelVecchio, Vito G., Gallia, Gary L., & McCleskey, Ferne K.. Detection and prevention of mycoplasma hominis infection. United States.
DelVecchio, Vito G., Gallia, Gary L., and McCleskey, Ferne K.. Tue . "Detection and prevention of mycoplasma hominis infection". United States. doi:. https://www.osti.gov/servlets/purl/870792.
@article{osti_870792,
title = {Detection and prevention of mycoplasma hominis infection},
author = {DelVecchio, Vito G. and Gallia, Gary L. and McCleskey, Ferne K.},
abstractNote = {The present invention is directed to a rapid and sensitive method for detecting Mycoplasma hominis using M. hominis-specific probes, oligonucleotides or antibodies. In particular a target sequence can be amplified by in vitro nucleic acid amplification techniques, detected by nucleic acid hybridization using the subject probes and oligonucleotides or detected by immunoassay using M. hominis-specific antibodies. M. hominis-specific nucleic acids which do not recognize or hybridize to genomic nucleic acid of other Mycoplasma species are also provided.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Jan 21 00:00:00 EST 1997},
month = {Tue Jan 21 00:00:00 EST 1997}
}

Patent:

Save / Share:
  • Highlights: • This study generates a monoclonal antibody CA27 against the mycoplasmal p37 protein. • CA27 isolates circulating tumor cells (CTCs) from the blood of liver cancer patients. • Results show the first evidence for mycoplasma infected-CTCs in cancer patients. - Abstract: Many studies have shown that persistent infections of bacteria promote carcinogenesis and metastasis. Infectious agents and their products can modulate cancer progression through the induction of host inflammatory and immune responses. The presence of circulating tumor cells (CTCs) is considered as an important indicator in the metastatic cascade. We unintentionally produced a monoclonal antibody (MAb) CA27 against themore » mycoplasmal p37 protein in mycoplasma-infected cancer cells during the searching process of novel surface markers of CTCs. Mycoplasma-infected cells were enriched by CA27-conjugated magnetic beads in the peripheral blood mononuclear cells in patients with hepatocellular carcinoma (HCC) and analyzed by confocal microscopy with anti-CD45 and CA27 antibodies. CD45-negative and CA27-positive cells were readily detected in three out of seven patients (range 12–30/8.5 ml blood), indicating that they are mycoplasma-infected circulating epithelial cells. CA27-positive cells had larger size than CD45-positive hematological lineage cells, high nuclear to cytoplasmic ratios and irregular nuclear morphology, which identified them as CTCs. The results show for the first time the existence of mycoplasma-infected CTCs in patients with HCC and suggest a possible correlation between mycoplasma infection and the development of cancer metastasis.« less
  • An environmentally acceptable gas is provided, under pressure, in the annulus of a casing arrangement which connects a wellhead to an underground storage zone containing stored product. Monitoring of the gas permits detection of leaks that might occur through casing leakage to an unsealed overburden. Leak detection and product loss prevention can be conducted without deleterious environmental impact.
  • A case of acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection was treated in an 8-year-old girl. She experienced acute pancreatitis during treatment for M. pneumoniae. Contrast-enhanced computed tomographic scan revealed necrotizing pancreatitis. The computed tomographic severity index was 8 points (grade E). A protease inhibitor, ulinastatin, was provided via intravenous infusion but was ineffective. Continuous regional arterial infusion therapy was provided with gabexate mesilate (FOY-007, a protease inhibitor) and meropenem trihydrate, and the pancreatitis improved. This case suggests that infusion therapy is safe and useful in treating necrotizing pancreatitis in children.
  • Novel biotin amide analogs that are useful for targeting therapeutic and imaging agents to sites of infection and tumors in vivo are disclosed.